AVP-786 - Alzheimer's News Today
WEBAug 17, 2019 · AVP-786 is a combination of dextromethorphan and quinidine, with deuterium, that may reduce agitation in Alzheimer's patients. It is in Phase 3 clinical trials and has a fast track designation by the FDA.
Neurostimulation Device for Alzheimers Granted FDA …
WEBJan 25, 2021 · Cognito Therapeutics' device, using gamma frequency technology, is a non-invasive digital therapeutic that aims to treat memory and cognition symptoms in Alzheimer's disease. The device has been granted a breakthrough device designation by the FDA, based on promising outcomes in multiple clinical studies.
Exelon (Rivastigmine) - Alzheimer's News Today
WEBExelon is a cholinesterase inhibitor that increases acetylcholine levels in the brain and improves cognition and daily function in AD patients. It is available in capsule or patch form and can slow down the progression of AD symptoms, but not the disease itself.
ALZT-OP1 - Alzheimer's News Today
WEBAug 18, 2019 · ALZT-OP1 is a combined oral-inhaled therapy being developed by Boston-based AZTherapies to slow the progression of early Alzheimer’s disease.. How ALZT-OP1 works. In Alzheimer’s, inflammation of the brain, or neuroinflammation, can destroy brain cells.This is caused by long-term activation of brain immune cells, such as astrocytes and microglia, that release excessive amounts of ...
MemTrax, An Online Test, Helps Track Cognitive Problems in …
WEBJul 12, 2019 · MemTrax is a test that analyzes the ability to recognize images and predict the progression of cognitive problems in Alzheimer's and other disorders. A study using artificial intelligence found that MemTrax can assess short-term memory and compare with other screening tools.
Aricept (Donepezil) - Alzheimer's News Today
WEBAricept is a cholinesterase inhibitor that increases acetylcholine levels in the brain and improves cognition and function in Alzheimer's patients. It can cause common adverse effects such as nausea, insomnia, and fatigue, but …
Alzheimer’s Disease Is Not a Mental Illness
WEBMay 17, 2021 · Alzheimer's disease is a brain disorder that affects memory, reasoning, and daily function, while mental illness is a condition that affects mood, behavior, and thinking. Learn how to distinguish between the two, why stigma is a barrier to diagnosis and treatment, and how to seek help.
Simufilam (PTI-125) - Alzheimer's News Today
WEBJan 17, 2022 · Simufilam is a small molecule that targets misfolded filamin A, a protein involved in Alzheimer's pathology. It is being tested in Phase 2 and Phase 3 clinical trials to assess its safety, efficacy, and cognitive benefits in …
Aduhelm (Aducanumab)
WEBJun 7, 2021 · Aduhelm (aducanumab) is a monoclonal antibody that binds to aggregated amyloid-beta plaques in the brain and reduces their levels. It is the first targeted therapy for Alzheimer's disease, approved by the FDA in 2021 under accelerated approval pathway.
Latest Data on Alzheimer's Drug Namenda Confirms Beneficial …
WEBApr 24, 2017 · Namenda (memantine) is an FDA-approved drug that blocks brain receptors associated with Alzheimer's symptoms. It can delay functional decline, reduce agitation and improve cognition in moderate to severe Alzheimer's patients, especially when combined with Aricept (donepezil).